In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

A Beverly Hills surgeon is suing Medtronic claiming patent infringement of her hernia repair mesh product. It's the latest in ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Consumers saw price relief at the gas pump and grocery store. But housing inflation and other categories, such as car ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

"Rising Chronic Disease Cases and Advancements in Medical Technology Drive Rapid Growth in the Infusion Pump Market" BOSTON, ...

Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...